Alnylam Pharmaceuticals
ALNY
#567
Rank
โ‚ฌ34.15 B
Marketcap
265,00ย โ‚ฌ
Share price
-2.20%
Change (1 day)
71.25%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company